These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7954615)

  • 21. Involvement of ATP-sensitive potassium channels in preconditioning protection.
    Rohmann S; Weygandt H; Schelling P; Kie Soei L; Verdouw PD; Lues I
    Basic Res Cardiol; 1994; 89(6):563-76. PubMed ID: 7702545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ischaemic preconditioning limits infarct size in the rat heart.
    Yellon DM; Alkhulaifi AM; Browne EE; Pugsley WB
    Cardiovasc Res; 1992 Oct; 26(10):983-7. PubMed ID: 1486593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ischaemic preconditioning protects hypertrophied myocardium.
    Speechly-Dick ME; Baxter GF; Yellon DM
    Cardiovasc Res; 1994 Jul; 28(7):1025-9. PubMed ID: 7954588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypoxic preconditioning of ischaemic canine myocardium.
    Shizukuda Y; Mallet RT; Lee SC; Downey HF
    Cardiovasc Res; 1992 May; 26(5):534-42. PubMed ID: 1446323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamide.
    Toombs CF; Moore TL; Shebuski RJ
    Cardiovasc Res; 1993 Apr; 27(4):617-22. PubMed ID: 8324795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissociation between anti-infarct effect and anti-edema effect of ischemic preconditioning.
    Sanz E; García Dorado D; Oliveras J; Barrabés JA; Gonzalez MA; Ruiz-Meana M; Solares J; Carreras MJ; García-Lafuente A; Desco M
    Am J Physiol; 1995 Jan; 268(1 Pt 2):H233-41. PubMed ID: 7840267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction in infarct size by ischemic preconditioning persists in a chronic rat model of myocardial ischemia-reperfusion injury.
    Lott FD; Guo P; Toombs CF
    Pharmacology; 1996 Feb; 52(2):113-8. PubMed ID: 8851632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning.
    Tsuchida A; Miura T; Miki T; Shimamoto K; Iimura O
    Cardiovasc Res; 1992 May; 26(5):456-61. PubMed ID: 1446315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duration and reinstatement of myocardial protection against infarction by ischemic preconditioning in open chest dogs.
    Schwartz LM; Sebbag L; Jennings RB; Reimer KA
    J Mol Cell Cardiol; 2001 Sep; 33(9):1561-70. PubMed ID: 11549337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial protection with preconditioning.
    Li GC; Vasquez JA; Gallagher KP; Lucchesi BR
    Circulation; 1990 Aug; 82(2):609-19. PubMed ID: 2372907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size.
    Lasley RD; Konyn PJ; Hegge JO; Mentzer RM
    Am J Physiol; 1995 Oct; 269(4 Pt 2):H1460-6. PubMed ID: 7485581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An adenosine A1 receptor agonist, R(-)-N-(2-phenylisopropyl)-adenosine (PIA), but not adenosine itself, acts as a therapeutic preconditioning-mimetic agent in rabbits.
    Hale SL; Bellows SD; Hammerman H; Kloner RA
    Cardiovasc Res; 1993 Dec; 27(12):2140-5. PubMed ID: 8313421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No sex-related differences in infarct size, no-reflow, and protection by ischaemic pre-conditioning in Göttingen minipigs.
    Kleinbongard P; Lieder H; Skyschally A; Heusch G
    Cardiovasc Res; 2023 Mar; 119(2):561-570. PubMed ID: 35426434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvage of ischaemic myocardium by reperfusion: importance of collateral blood flow and myocardial oxygen demand during occlusion.
    Przyklenk K; Vivaldi MT; Schoen FJ; Malcolm J; Arnold O; Kloner RA
    Cardiovasc Res; 1986 Jun; 20(6):403-14. PubMed ID: 3779738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Superoxide dismutase and N-2-mercaptopropionyl glycine attenuate infarct size limitation effect of ischaemic preconditioning in the rabbit.
    Tanaka M; Fujiwara H; Yamasaki K; Sasayama S
    Cardiovasc Res; 1994 Jul; 28(7):980-6. PubMed ID: 7954610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smaller infarct after preconditioning does not predict extent of early functional improvement of reperfused heart.
    Cohen MV; Yang XM; Downey JM
    Am J Physiol; 1999 Nov; 277(5):H1754-61. PubMed ID: 10564128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin II receptor antagonist EXP 3174 reduces infarct size comparable with enalaprilat and augments preconditioning in the pig heart.
    Schwarz ER; Montino H; Fleischhauer J; Klues HG; vom Dahl J; Hanrath P
    Cardiovasc Drugs Ther; 1997 Nov; 11(5):687-95. PubMed ID: 9493708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
    Bril A; Slivjak M; DiMartino MJ; Feuerstein GZ; Linee P; Poyser RH; Ruffolo RR; Smith EF
    Cardiovasc Res; 1992 May; 26(5):518-25. PubMed ID: 1359930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duration of ischaemic preconditioning and importance of size of area at risk in pigs.
    Grund F; Gjesdal K; Kirkeboen KA; Ilebekk A
    J Mol Cell Cardiol; 1999 Jul; 31(7):1369-80. PubMed ID: 10403754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.